Value Lens: Gland Pharma may be cheaper than global firms but hovers above locals

Premium

The proposed initial public offering of Gland Pharma Ltd values the maker of injectable drugs at a premium to locally listed drugmakers but assigns a steep discount to overseas publicly listed companies, a VCCircle analysis shows. The Hyderabad-based company filed for the IPO earlier this month, barely three years after it ......